The Effect Of Return On Assets (Roa) And Return On Equity (Roe) Towards Changes In Share Prices
Main Article Content
Abstract
This study aims to test and prove the effect of Return On Assets (ROA) and Return On Equity (ROE) on share prices in the pharmaceutical industry listed on the IDX. The population in the study of pharmaceutical companies listed on the IDX in the 2015-2019 period and the sample used were 6 pharmaceutical companies with a purposive sampling technique. The results of this study indicate that partially ROA has no effect on share prices. In addition, ROE also partially has no effect on share prices. And simultaneously ROA and ROE have no effect on share prices in pharmaceutical companies listed on the IDX in the 2015-2019 period.
Downloads
Metrics
Article Details
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.